Is VAX up or down today?
VAX is up 1.39% today, last at 321.18. This stock moved +1.39% versus the prior close.
VAX · VAX
VAX (VAX) is trading at 321.18, up 1.39% on the session. VAX sits at the 50% mark of its 52-week range.
Leading the coverage: “Vaxcyte PCVX Soars As VAX-31 Phase 3 Data Stun Wall Street - Timothy Sykes” (Google News Company, 20d ago). VAX is +0.39% since story.
VAX trades on a trailing P/E of 21.2.
Analyst firms are mostly reiterating — no strong directional shift lately.
VAX is up 1.39% today, last at 321.18. This stock moved +1.39% versus the prior close.
Leading the coverage: “Vaxcyte PCVX Soars As VAX-31 Phase 3 Data Stun Wall Street - Timothy Sykes” (Google News Company, 20d ago). VAX is +0.39% since story. Dominant story: Vaxcyte PCVX Soars As VAX-31 Phase 3 Data Stun Wall Street - Timothy Sykes (1 source, bullish) RSI unavailable Price sits at 50% of its 52-week range Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Historical price chart unavailable
Live quote in the header is real, but OHLC history could not be loaded from Yahoo Finance or fallback providers. Charts use Yahoo when configured correctly — check server logs for provider errors.
Vaxcyte PCVX Soars As VAX-31 Phase 3 Data Stun Wall Street - Timothy Sykes
Vaxcyte VAX-31 pneumococcal vaccine phase 3 trial results
Vaxcyte’s VAX-31 Meets All Primary Endpoints in Pivotal Phase III OPUS-1 Trial
Vaxcyte Shares Rise 50% After VAX-31 Meets Primary Endpoints in Phase 3 Trial - Yahoo Finance
ESMO: Evaxion hopes cancer vax data attract partner after cash crunch forces smaller phase 2 trial - Fierce Biotech